Arrowhead Pharmaceuticals, Inc. (NASDAQ ... in this deal soaks up current excess manufacturing capacity in our new Verona manufacturing plant and to defrayes our operating costs.
--(BUSINESS WIRE)--Arrowhead Pharmaceuticals ... published in The New England Journal of Medicine. Arrowhead's Verona, WI manufacturing and testing facility successfully completed requirements ...
Guidewire Software Inc. (NYSE: GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead Pharmaceuticals will replace Barnes Group Inc. (NYSE: B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback